Zeke Capital Advisors, LLC Gilead Sciences, Inc. Transaction History

Zeke Capital Advisors, LLC

$1.53 Billion
Q4 2022

A detailed history of Zeke Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 6,561 shares of GILD stock, worth $549,943. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,561

Previous 6,445 1.8%

Holding current value

$549,943

Previous $397,000 41.81%

% of portfolio

0.04%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $7,229 - $10,378	116 Added 1.8%	6,561 $563,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $6,787 - $7,753	114 Added 1.8%	6,445 $397,000
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $7,503 - $8,451	-130 Reduced 2.01%	6,331 $392,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $374,221 - $468,939	6,461 New	6,461 $385,000
Q1 2020 Apr 24, 2020	SELL	$62.63 - $80.22 $2.26 Million - $2.89 Million	-36,044 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$61.62 - $67.78 $1.35 Million - $1.48 Million	21,872 Added 154.33%	36,044 $2.34 Million
Q3 2019 Oct 18, 2019	SELL	$62.51 - $69.0 $563,465 - $621,966	-9,014 Reduced 38.88%	14,172 $898,000
Q2 2019 Jul 24, 2019	BUY	$61.87 - $69.38 $47,949 - $53,769	775 Added 3.46%	23,186 $1.57 Million
Q1 2019 Apr 29, 2019	BUY	$62.53 - $70.05 $179,711 - $201,323	2,874 Added 14.71%	22,411 $1.46 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $92,989 - $121,344	1,536 Added 8.53%	19,537 $1.22 Million
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $300,730 - $332,963	4,219 Added 30.61%	18,001 $1.39 Million
Q2 2018 Jul 24, 2018	SELL	$64.88 - $75.68 $1.31 Million - $1.53 Million	-20,241 Reduced 59.49%	13,782 $976,000
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $1.2 Million - $1.46 Million	16,473 Added 93.86%	34,023 $2.57 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $456,925 - $536,365	-6,422 Reduced 26.79%	17,550 $1.26 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $1.73 Million - $2.05 Million	23,972	23,972 $1.94 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Account

Zeke Capital Advisors, LLC Gilead Sciences, Inc. Transaction History